Log in
Enquire now
Finch Therapeutics Group

Finch Therapeutics Group

Finch Therapeutics Group is a clinical-stage biopharma company established by the founders of OpenBiome.

OverviewStructured DataIssuesContributors

Contents

finchtherapeutics.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Biomedical engineering
Biomedical engineering
Engineering
Engineering
Technology
Technology
Biotechnology
Biotechnology
Biology
Biology
Therapeutics
Therapeutics
‌
Pharmaceuticals
...
Location
Somerville, Massachusetts
Somerville, Massachusetts
0
Massachusetts
Massachusetts
0
B2X
B2B
B2B
CEO
Mark Smith
Mark Smith
0
Founder
Andrew Noh
Andrew Noh
Eric Alm
Eric Alm
‌
Thomas Borody
James Burgess
James Burgess
Zain Kassam
Zain Kassam
Mark Smith
Mark Smith
0
AngelList URL
angel.co/finch-therapeutics
Pitchbook URL
pitchbook.com/profiles...121468-06
Legal Name
Finch Therapeutics Group Inc.
Legal classification
Incorporation (business)
Incorporation (business)
Limited liability company
Limited liability company
Corporation
Corporation
Date Incorporated
2018
Number of Employees (Ranges)
11 – 500
Email Address
collaborations@finchtherapeutics.com0
info@finchtherapeutics.com0
media@finchtherapeutics.com0
ir@finchtherapeutics.com0
Phone Number
+161722964990
Full Address
200 Inner Belt Road Suite 400 Somerville, MA 02143 United States0
CIK Number
1,733,2570
Place of Incorporation
Delaware
Delaware
0
Investors
Avenir Growth Capital
Avenir Growth Capital
Powder Gate Capital
Powder Gate Capital
Willett Advisors LLC
Willett Advisors LLC
Humboldt Fund
Humboldt Fund
Octave Group
Octave Group
OMX Ventures
OMX Ventures
SIG
SIG
‌
Symbiosis Group
...
IRS Number
823,433,5580
Total Funding Amount (USD)
211,299,996
Latest Funding Round Date
September 2020
Competitors
Viome
Viome
Business Model
Advertising
Stock Symbol
FNCH0
Exchange
Nasdaq
Nasdaq
0
Board of Directors
Mark Smith
Mark Smith
0
‌
Christian Lange
0
‌
Jo Viney
0
Chris Shumway
Chris Shumway
0
CTO
‌
Bryan Gillis,
0
Latest Funding Type
Series D
Series D
COO
‌
Marc Blaustein
0
Wellfound ID
finch-therapeutics
Country
United States
United States
0

Other attributes

Company Operating Status
Active
Contact Page URL
finchtherapeutics.com/about/
SIC Code
2,8360
Ticker Symbol
FNCH

Finch Therapeutics Group is a biopharma company developing therapeutics through the human microbiome in a human-first discovery platform. The company has an ongoing Phase 2 FDA clinical trial for recurrent C. difficile infection.

Patents solely owned by Finch

US Patent Number
Covers the use of
Owned until

10,022,406

Donor-derived compositions

2031

9,901,603

Lyophilized formulations of microbial therapies

2036

9,962,413

Screened, healthy donors in the manufacture of microbial therapies

2031

9,962,414

Pharmaceutical compositions containing a plurality of Clostridium species

2021

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Finch Therapeutics Group

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us